Karen Lee - Maxigen Biotech Sr Admin
| 1783 Stock | TWD 44.60 1.15 2.65% |
Insider
Karen Lee is Sr Admin of Maxigen Biotech
| Phone | 886 3 328 7222 |
| Web | https://mbi-bio.com |
Karen Lee Latest Insider Activity
Tracking and analyzing the buying and selling activities of Karen Lee against Maxigen Biotech stock is an integral part of due diligence when investing in Maxigen Biotech. Karen Lee insider activity provides valuable insight into whether Maxigen Biotech is net buyers or sellers over its current business cycle. Note, Maxigen Biotech insiders must abide by specific rules, including filing SEC forms every time they buy or sell Maxigen Biotech'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Karen Lee over a week ago Acquisition by Karen Lee of 1156 shares of Northwest Natural at 42.12 subject to Rule 16b-3 | ||
Karen Lee over three months ago Acquisition by Karen Lee of 1276 shares of Northwest Natural at 38.09 subject to Rule 16b-3 | ||
Karen Lee over six months ago Acquisition by Karen Lee of 1333 shares of Northwest Natural at 36.6 subject to Rule 16b-3 |
Maxigen Biotech Management Efficiency
The company has return on total asset (ROA) of 0.0454 % which means that it generated a profit of $0.0454 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0926 %, meaning that it generated $0.0926 on every $100 dollars invested by stockholders. Maxigen Biotech's management efficiency ratios could be used to measure how well Maxigen Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 8 records | INSIDER Age | ||
| Kevin Lin | Phytohealth Corp | N/A | |
| Chih Huang | Phytohealth Corp | N/A | |
| Fred Lai | Phytohealth Corp | N/A | |
| Yi Li | Phytohealth Corp | N/A | |
| Yufang Wang | Yung Zip Chemical | N/A | |
| ILin Lee | Phytohealth Corp | N/A | |
| YiLi Lee | Phytohealth Corp | N/A | |
| Li Yeh | Phytohealth Corp | N/A | |
Management Performance
| Return On Equity | 0.0926 | |||
| Return On Asset | 0.0454 |
Maxigen Biotech Leadership Team
Elected by the shareholders, the Maxigen Biotech's board of directors comprises two types of representatives: Maxigen Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Maxigen. The board's role is to monitor Maxigen Biotech's management team and ensure that shareholders' interests are well served. Maxigen Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Maxigen Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| PoHung Lai, Deputy Mang | ||
| ChingTing Chen, GM Director | ||
| WanHow You, Financial Officer | ||
| Karen Lee, Sr Admin |
Maxigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Maxigen Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0926 | |||
| Return On Asset | 0.0454 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 3.32 B | |||
| Shares Outstanding | 84.7 M | |||
| Shares Owned By Insiders | 51.89 % | |||
| Shares Owned By Institutions | 2.28 % | |||
| Price To Earning | 33.55 X | |||
| Price To Book | 3.24 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Maxigen Stock Analysis
When running Maxigen Biotech's price analysis, check to measure Maxigen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maxigen Biotech is operating at the current time. Most of Maxigen Biotech's value examination focuses on studying past and present price action to predict the probability of Maxigen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maxigen Biotech's price. Additionally, you may evaluate how the addition of Maxigen Biotech to your portfolios can decrease your overall portfolio volatility.